These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32706879)

  • 1. Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study.
    Le Bot A; Lecomte R; Gazeau P; Benezit F; Arvieux C; Ansart S; Boutoille D; Le Berre R; Chabanne C; Lesouhaitier M; Dejoies L; Flecher E; Chapplain JM; Tattevin P; Revest M
    Clin Infect Dis; 2021 May; 72(9):e249-e255. PubMed ID: 32706879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.
    Chu VH; Miro JM; Hoen B; Cabell CH; Pappas PA; Jones P; Stryjewski ME; Anguera I; Braun S; Muñoz P; Commerford P; Tornos P; Francis J; Oyonarte M; Selton-Suty C; Morris AJ; Habib G; Almirante B; Sexton DJ; Corey GR; Fowler VG;
    Heart; 2009 Apr; 95(7):570-6. PubMed ID: 18952633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.
    Shrestha NK; Shah SY; Wang H; Hussain ST; Pettersson GB; Nowacki AS; Gordon SM
    Ann Thorac Surg; 2016 Jun; 101(6):2243-50. PubMed ID: 26872729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary clinical profile and outcome of prosthetic valve endocarditis.
    Wang A; Athan E; Pappas PA; Fowler VG; Olaison L; Paré C; Almirante B; Muñoz P; Rizzi M; Naber C; Logar M; Tattevin P; Iarussi DL; Selton-Suty C; Jones SB; Casabé J; Morris A; Corey GR; Cabell CH;
    JAMA; 2007 Mar; 297(12):1354-61. PubMed ID: 17392239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.
    Fernández Guerrero ML; González López JJ; Goyenechea A; Fraile J; de Górgolas M
    Medicine (Baltimore); 2009 Jan; 88(1):1-22. PubMed ID: 19352296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of Staphylococcus capitis prosthetic valve infective endocarditis: Retrospective review of a 10-year single center experience and review of the literature.
    Tchana-Sato V; Hans G; Frippiat F; Zekhnini I; Dulgheru R; Lavigne JP; Defraigne JO
    J Infect Public Health; 2020 Nov; 13(11):1705-1709. PubMed ID: 33055006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
    Ramos-Martínez A; Muñoz Serrano A; de Alarcón González A; Muñoz P; Fernández-Cruz A; Valerio M; Fariñas MC; Gutiérrez-Cuadra M; Miró JM; Ruiz-Morales J; Sousa-Regueiro D; Montejo JM; Gálvez-Acebal J; HidalgoTenorio C; Domínguez F;
    J Infect Chemother; 2018 Jul; 24(7):555-562. PubMed ID: 29628387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.
    Galar A; Weil AA; Dudzinski DM; Muñoz P; Siedner MJ
    Clin Microbiol Rev; 2019 Mar; 32(2):. PubMed ID: 30760474
    [No Abstract]   [Full Text] [Related]  

  • 10. Prosthetic valve endocarditis due to Propionibacterium acnes.
    van Valen R; de Lind van Wijngaarden RA; Verkaik NJ; Mokhles MM; Bogers AJ
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):150-5. PubMed ID: 27052748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database.
    Lalani T; Kanafani ZA; Chu VH; Moore L; Corey GR; Pappas P; Woods CW; Cabell CH; Hoen B; Selton-Suty C; Doco-Lecompte T; Chirouze C; Raoult D; Miro JM; Mestres CA; Olaison L; Eykyn S; Abrutyn E; Fowler VG;
    Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):365-8. PubMed ID: 16767483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?
    Truninger K; Attenhofer Jost CH; Seifert B; Vogt PR; Follath F; Schaffner A; Jenni R
    Heart; 1999 Dec; 82(6):714-20. PubMed ID: 10573500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death.
    John MD; Hibberd PL; Karchmer AW; Sleeper LA; Calderwood SB
    Clin Infect Dis; 1998 Jun; 26(6):1302-9. PubMed ID: 9636852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
    Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
    JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Staphylococcus aureus prosthetic valve endocarditis.
    Hassoun A
    Am J Med; 2007 Mar; 120(3):e9; author reply e11. PubMed ID: 17349434
    [No Abstract]   [Full Text] [Related]  

  • 16. Aortic valve endocarditis. Determinants of early survival and late morbidity.
    Aranki SF; Santini F; Adams DH; Rizzo RJ; Couper GS; Kinchla NM; Gildea JS; Collins JJ; Cohn LH
    Circulation; 1994 Nov; 90(5 Pt 2):II175-82. PubMed ID: 7955248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.
    Souli M; Pontikis K; Chryssouli Z; Galani I; Giamarellou H
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):760-2. PubMed ID: 16283218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment outcome of prosthetic valve endocarditis].
    Abramczuk E; Rawczyńska-Englert I; Grabowski M; Jarnicka W
    Przegl Lek; 2003; 60(9):549-52. PubMed ID: 15065330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.
    Riedel DJ; Weekes E; Forrest GN
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2463-7. PubMed ID: 18474578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
    Karchmer AW; Archer GL; Dismukes WE
    Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.